4//SEC Filing
WASSON GREGORY D 4
Accession 0001628280-23-029924
CIK 0001448431other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 9:28 AM ET
Size
9.4 KB
Accession
0001628280-23-029924
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
WASSON GREGORY D
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-07+4,637→ 23,968 total - Exercise/Conversion
Restricted Stock Units
2023-06-07−4,637→ 0 total→ Common Stock (4,637 underlying) - Award
Restricted Stock Units
2023-06-07+10,061→ 10,061 total→ Common Stock (10,061 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023.
- [F3]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F4]The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001188827
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 9:28 AM ET
- Size
- 9.4 KB